Related Experiment Video
Updated: Feb 28, 2026
07:49
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
3.3K
Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells
Xiaoli Li1,2, Gaoyang Han3, Xiaoran Li2
1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, 450000, China.
Oncotarget
|June 19, 2017
Summary
Disabling the mitochondrial pyruvate carrier 1 (MPC1) gene reprograms cancer cells to aerobic glycolysis, increasing migration and resistance. This highlights MPC1
Area of Science:
- Cancer Biology
- Cell Metabolism
- Mitochondrial Function
Background:
- Cancer cells exhibit aerobic glycolysis (Warburg Effect), relying on glycolysis over oxidative phosphorylation (OXPHOS) for ATP.
- Mitochondrial dysfunction forces cells to utilize glycolysis for energy, impacting cellular behavior.
- The mitochondrial pyruvate carrier (MPC) is crucial for shuttling pyruvate into mitochondria.
Purpose of the Study:
- To investigate the role of the mitochondrial pyruvate carrier 1 (MPC1) in cancer cell metabolism and stemness.
- To determine the impact of MPC1 gene knockout on cancer cell behavior, including migration and treatment resistance.
- To explore the correlation between MPC gene function, metabolic reprogramming, and cancer stem cell markers.
Main Methods:
- Prostate cancer cell line with MPC1 gene knockout.
- Analysis of cellular ATP production, migration, and resistance to chemotherapy/radiotherapy.
- Assessment of stemness markers (Nanog, Hif1α, Notch1, CD44, ALDH) via gene expression.
- Application of MPC inhibitor UK5099 in ovarian cancer cell lines.
Main Results:
- MPC1 knockout induced metabolic reprogramming towards aerobic glycolysis and reduced ATP production.
- MPC1 knockout cells exhibited increased migration and resistance to chemotherapy and radiotherapy.
- Elevated expression of stemness markers (Nanog, Hif1α, Notch1, CD44, ALDH) was observed in MPC1 knockout cells.
- MPC inhibitor UK5099 treatment in ovarian cancer cells mirrored these metabolic and stemness changes.
Conclusions:
- Functional MPC is critical for regulating cancer cell metabolic programs.
- MPC activity influences cancer cell stemness and in vitro behavior.
- Targeting MPC may offer a strategy to overcome metabolic reprogramming and stemness in cancer.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
02:40Cancer Stem Cells and Tumor Maintenance
6.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K
01:46Electron Transport Chain: Complex I and II
19.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.3K
01:20Fates of Pyruvate
11.5K
Pyruvate is the end product of glycolysis, where glucose is oxidized to pyruvate, simultaneously reducing NAD+ to NADH. Two molecules of ATP are also produced by substrate-level phosphorylation.
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
11.5K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
01:15Pyruvate Oxidation
169.9K
After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
169.9K